Evidence map›Paper›PMID 41048210›Full record

ArticleTransboundary and emerging diseases2025

Molecular Epidemiology, Lineage Evolutionary Dynamics, and Antigenic Variation Analysis of Type II PRRSV in China During 2024-2025.

Dihua Zhu, Guangyu Liu, Huixin Li, Fen Li, Xiaolong Xu, Yuanyuan Fu, Pandan Chen, Guihong Zhang, Yankuo Sun

Erratum issuedAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Dihua ZhuGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Guangyu LiuGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.ORCID https://orcid.org/0009-0005-6668-4446
Huixin LiGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Fen LiAnimal Husbandry and Veterinary Service Center of Ledong Li Autonomous County, Hainan Province, China.
Xiaolong XuGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Yuanyuan FuGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Pandan ChenGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.
Guihong ZhangGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.ORCID https://orcid.org/0000-0003-1236-1850
Yankuo SunGuangdong Provincial Key Laboratory of Zoonosis Prevention and Control, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, China.ORCID https://orcid.org/0009-0004-4647-6204

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome virus (PRRSV) represents one of the major threats to the global swine industry, with its rapid evolution and antigenic variation posing persistent challenges to disease control. Based on 328 clinical samples collected from PRRSV symptomatic (respiratory disorders, reproductive failures, and high fever) pigs across 27 provinces in China during 2024-2025, this study employed open reading frame (ORF) 5 gene sequencing, complete genome sequencing of representative strains from key lineages (including a rapidly spreading NADC30-like Lineage 1.8 strain, a vaccine-related Lineage 8.7 strain, and a genetically distinct Lineage 3 strain), phylogenetic analysis, transmission dynamics analysis, intrahost single nucleotide variant (iSNV) analysis, and recombination detection to systematically reveal the molecular epidemiological characteristics and evolutionary dynamics of type II PRRSV currently circulating in China. The results demonstrated a complex pattern of coexistence among five major lineages of type II PRRSV in China, including Lineage 1.5, Lineage 1.8, Lineage 3, Lineage 5, and Lineage 8.7, with Lineage 1.8 emerging as the predominant circulating strain (48.5% of positive samples), followed by Lineage 1.5 (23.2%), while Lineages 3, 5, and 8.7 showed more restricted geographical distribution. Spatial transmission analysis identified Guangdong and Henan as key transmission nodes, forming "viral exchange centers" connecting northern and southern regions, while Hubei, Shanxi, and Jiangsu have become new viral aggregation sites. Genetic diversity analysis revealed high haplotype diversity (Hd) across all lineages except Lineage 5, with Lineage 5 showing a remarkable 106.6% increase in nucleotide diversity within 1 year, indicating rapid adaptive evolution. Tajima's D test results revealed negative values for most lineages, with Lineage 5 and 8.7 reaching statistical significance, suggesting these viral populations have undergone recent population expansion or directional selection. Multidimensional scaling (MDS) analysis based on genetic distance revealed a potential antigenic divergence between the predominant circulating lineages (1.8 and 3) and current vaccine strains, which may compromise vaccine efficacy. In-depth analysis of three representative genomes revealed complex recombination patterns involving vaccine-related strains and identified the ORF2-ORF3 region as a potential recombination hotspot. The findings of this study provide a scientific basis for understanding the evolutionary mechanisms of type II PRRSV in China and offer important references for formulating targeted control strategies and optimizing vaccine design, which has significant value for ensuring the healthy development of China's swine industry in the post-African swine fever era.

Indexed as

Antigenic VariationEvolution, MolecularPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusAnimalsChinaGenetic VariationMolecular EpidemiologyPhylogenySwineantigenic variationgene recombinationintrahost single nucleotide variantlineage evolutionmolecular epidemiologyporcine reproductive and respiratory syndrome virustransmission dynamics

Identifiers

PMID41048210
PMCPMC12496146

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.